Related Experiment Video
Updated: Aug 6, 2026

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Review article: should we kill or should we save Helicobacter pylori?
R H Hunt1, K Sumanac, J Q Huang
1Division of Gastroenterology, Department of Medicine, McMaster University Medical Center, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada. huntr@fhs.csu.mcmaster.ca
Helicobacter pylori infection causes gastritis and peptic ulcers, and its eradication resolves these conditions and prevents recurrence. While some question eradication, evidence confirms H. pylori is a significant pathogen.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Oncology
Background:
- Helicobacter pylori infection is a primary cause of gastritis and peptic ulcer disease.
- It also contributes to gastric atrophy, intestinal metaplasia, and gastric cancer development.
- H. pylori is implicated in gastric MALT lymphoma, with eradication leading to tumor regression.
Purpose of the Study:
- To review the evidence on Helicobacter pylori's role in gastrointestinal diseases.
- To evaluate the benefits of H. pylori eradication therapy.
- To address ongoing debates regarding the necessity of universal H. pylori eradication.
Main Methods:
- Review of epidemiological studies and therapeutic clinical trials.
- Analysis of literature on H. pylori's impact on gastritis, peptic ulcers, gastric cancer, and MALT lymphoma.
- Evaluation of arguments for and against H. pylori eradication.
Main Results:
- H. pylori eradication resolves gastritis, accelerates ulcer healing, and prevents duodenal ulcer recurrence.
- Eradication leads to regression of gastric MALT lymphoma in over 80% of patients.
- Preliminary data suggest eradication may reduce metachronous gastric cancer and prevent adenoma progression.
Conclusions:
- Despite some questioning, H. pylori is a serious pathogen, particularly in those who develop clinical consequences.
- The benefits of eradication for gastritis, peptic ulcers, and MALT lymphoma are well-established.
- Further prospective studies are needed to definitively address hypotheses questioning universal eradication.
More Related Videos
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology

